Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study

OBJECTIVES: Oral direct-acting antivirals (DAAs) for hepatitis C virus (HCV) have dramatically changed the treatment paradigm. Our aim was to project temporal trends in HCV diagnosis, treatment and disease burden in France, Germany, Italy, Spain and the UK. DESIGN: A mathematical simulation model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiushi, Ayer, Turgay, Bethea, Emily, Kanwal, Fasiha, Wang, Xiaojie, Roberts, Mark, Zhuo, Yueran, Fagiuoli, Stefano, Petersen, Jorg, Chhatwal, Jagpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576109/
https://www.ncbi.nlm.nih.gov/pubmed/31189677
http://dx.doi.org/10.1136/bmjopen-2018-026726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576109/
https://www.ncbi.nlm.nih.gov/pubmed/31189677
http://dx.doi.org/10.1136/bmjopen-2018-026726

Ejemplares similares